Serial Number
90046614
Owner
Capsida, Inc.Attorney
Holly PrangerFirst Use Date
Jul 5, 2024
Filing Date
Jul 10, 2020
CAPSIDA BIOTHERAPEUTICS Trademark
Serial Number: 90046614 • Registration: 8196323
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Holly Pranger PRANGER LAW PC
88 GUY PLACE, SUITE 405
SAN FRANCISCO, CA 94105
United States
Trademark Details
Filing Date
July 10, 2020
Registration Date
March 31, 2026
First Use Anywhere
July 5, 2024
First Use in Commerce
July 5, 2024
Published for Opposition
February 7, 2023
Goods & Services
Pharmaceutical research and development in the field of gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development in the field of cardiovascular, central nervous system, neurological, ophthalmologic, and peripheral nervous system diseases and disorders and complications associated therewith; scientific research and product development services for others in the pharmaceutical, biotechnology, and medical fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical research and development, scientific research and development, pharmaceutical research and development and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; biomedical research in the field of gene therapy design and delivery; gene therapy design and product delivery development of biochemical assays; biomedical research and development, scientific research and development, pharmaceutical research and development and product development in the fields of cardiovascular, central nervous system, neurological, ophthalmologic, and peripheral nervous system diseases and disorders; medical services, namely, scientific research in the fields of genetic engineering and gene therapy services; medical services, namely, scientific research in the nature of gene therapy design and delivery services in the field of genetic diseases and disorders
Pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene delivery technology for use in the treatment of central nervous system, neurological, and peripheral nervous system diseases and disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases for use in the treatment of central nervous system, neurological, and peripheral nervous system diseases and disorders; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system, in the nature of drug delivery agents consisting of viral capsids that facilitate the delivery of the preparations; pre-filled vials containing pharmaceutical preparations for the treatment of central nervous system, neurological, and peripheral nervous system diseases and disorders and complications associated therewith
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences; Chemical and biochemical products for use in gene delivery technology namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, vectors, promotors, enhancers and other regulatory sequences for development of therapeutics and the treatment of cardiovascular, central nervous system, neurological, and peripheral nervous system diseases and disorders; Chemical and biochemical products for use in gene delivery technology namely, nucleic acids, including plasmids for development of therapeutics and the treatment of central nervous system, neurological, and peripheral nervous system diseases and disorders
